dan 2163 has been researched along with Neuroleptic Malignant Syndrome in 11 studies
Neuroleptic Malignant Syndrome: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The authors present a case of amisulpiride-induced catatonia, further evaluation suggested neuroleptic malignant syndrome (NMS) and showed the occurrence of temporal lobe epilepsy (TLE) and underlying brain pathology with marked frontoparietal atrophy and periventricular white matter hyperintensities." | 3.75 | Catatonia, neuroleptics and brain damage--a case report. ( Chandran, M; El-Shazly, M, 2009) |
| "An amisulpride-induced neuroleptic malignant syndrome was therefore diagnosed as the patho-physiological mechanism leading to death." | 1.39 | Lethal neuroleptic malignant syndrome due to amisulpride. ( Doberentz, E; Madea, B; Musshoff, F, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uvais, NA | 1 |
| Gangadhar, P | 1 |
| Sreeraj, VS | 1 |
| Rafeeque, PA | 1 |
| Barrimi, M | 1 |
| El Ghazouani, F | 1 |
| Zaimi, O | 1 |
| Oneib, B | 1 |
| Musshoff, F | 1 |
| Doberentz, E | 1 |
| Madea, B | 1 |
| Nabih, FO | 1 |
| Benali, A | 1 |
| Adali, I | 1 |
| Manoudi, F | 1 |
| Asri, F | 1 |
| Bonnet, U | 1 |
| Taazimi, B | 1 |
| Montag, M | 1 |
| Ronge, R | 1 |
| Gespers, H | 1 |
| Kuhlmann, R | 1 |
| Grabbe, D | 1 |
| Jahn, J | 1 |
| Chandran, M | 1 |
| El-Shazly, M | 1 |
| Yasugi, S | 1 |
| Garg, V | 1 |
| Been, G | 1 |
| Magoulas, P | 1 |
| Atbasoglu, EC | 1 |
| Ozguven, HD | 1 |
| Can Saka, M | 1 |
| Goker, C | 1 |
| Harter, C | 1 |
| Obier, C | 1 |
| Druschky, KF | 1 |
| Eikelmann, B | 1 |
| Abay, E | 1 |
| Kose, R | 1 |
| Bottlender, R | 1 |
| Jäger, M | 1 |
| Hofschuster, E | 1 |
| Dobmeier, P | 1 |
| Möller, HJ | 1 |
11 other studies available for dan 2163 and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Neuroleptic malignant syndrome (NMS) associated with amisulpride and sertraline use: A case report and discussion.
Topics: Aged; Amisulpride; Antipsychotic Agents; Depressive Disorder; Female; Humans; Neuroleptic Malignant | 2019 |
[Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode].
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Neuroleptic Malignant Syndr | 2018 |
Lethal neuroleptic malignant syndrome due to amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Autopsy; Cause of Death; Fatal Outcome; Forensic Pathology | 2013 |
[Association of atypical neuroleptics with anticonvulsants and malignant syndrome. Report of 2 cases].
Topics: Adolescent; Adult; Amisulpride; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Carbamazepin | 2014 |
Severe acute pancreatitis, neuroleptic malignant syndrome and grand mal seizures associated with elevated amisulpride and low clozapine serum levels.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Humans; Male; Middle Aged; Neuroleptic Malignant Syndr | 2015 |
Catatonia, neuroleptics and brain damage--a case report.
Topics: Amisulpride; Antipsychotic Agents; Atrophy; Catatonia; Epilepsy, Temporal Lobe; Female; Frontal Lobe | 2009 |
Neuroleptic malignant syndrome.
Topics: Adult; Amisulpride; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relation | 2010 |
Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome.
Topics: Adult; Amisulpride; Antipsychotic Agents; Coma; Creatine Kinase; Female; Humans; Leukocytosis; Neuro | 2004 |
[Malignant neuroleptic syndrome associated with amisulpride].
Topics: Affective Disorders, Psychotic; Amisulpride; Anticonvulsants; Antipsychotic Agents; Creatine Kinase; | 2008 |
Amisulpride-induced neuroleptic malignant syndrome.
Topics: Aged; Amisulpride; Antipsychotic Agents; Bipolar Disorder; Creatine Kinase; Humans; Male; Neurolepti | 2007 |
Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Female; Humans; Middle Aged; Neuroleptic Malignant Syn | 2002 |